News & Insights

Person

Date

  • Filter by dates

Active filters:

23.12.2022

GESSEL advises Pure Biologics S.A., a company listed on the Warsaw Stock Exchange

GESSEL supported Pure Biologics S.A. and its shareholders in preparation of a prospect-less public share offering via the accelerated book building pr...

Case studies
NEW!
GESSEL advises Pure Biologics S.A., a company listed on the Warsaw Stock Exchange

09.12.2022

GESSEL advises on sale of a majority stake in Suwary S.A.

GESSEL advised the Management Board of Suwary S.A. and its former shareholders, Wentworth Tech sp. z o.o. and Savtec sp. z o.o., on a PLN 100 mln sale of 65% of Suwary S...

News
GESSEL advises on sale of a majority stake in Suwary S.A.